KYNB Price / Book | KYNTRA BIO, INC.

KYNTRA BIO, INC. (KYNB) Price / Book

2022-09-30: Price/Book Ratio 1,161.43.
2022-06-30: Price/Book Ratio 238.44.
2022-03-31: Price/Book Ratio 177.37.
2021-12-31: Price/Book Ratio 156.54.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-12-31 to 2022-09-30
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2022-09-30	1,161.43
2022-06-30	238.44
2022-03-31	177.37
2021-12-31	156.54
2021-09-30	72.71
2021-06-30	236.6
2021-03-31	215.37
2020-12-31	200.84
2020-09-30	206.86
2020-06-30	230.94
2020-03-31	168.49
2019-12-31	182.1
2019-09-30	135.63
2019-06-30	155.94
2019-03-31	239.21
2018-12-31	194.12
2018-09-30	273.41
2018-06-30	265.87
2018-03-31	192.89
2017-12-31	184.99
2017-09-30	192.55
2017-06-30	249.06
2017-03-31	301.44
2016-12-31	218.57
2016-09-30	183.02
2016-06-30	133.29
2016-03-31	211.69
2015-12-31	265.93
2015-09-30	154.45
2015-06-30	139.85
2015-03-31	251.85
2014-12-31	182.28

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
Hepion Pharmaceuticals, Inc. (HEPA)	United States	$0.029B	-0.62
IGC Pharma, Inc. (IGC)	United States	$0.029B	-5.98
BeyondSpring Inc. (BYSI)	United States	$0.031B	-10.95
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62
NANOVIRICIDES, INC. (NNVC)	United States	$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)		$0.032B
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15
TherapeuticsMD, Inc. (TXMD)	United States	$0.024B	-117.87
Propanc Biopharma, Inc. (PPCB)		$0.032B	-0.13